SAN DIEGO, CA, Dec 06, 2021 (GLOBE NEWSWIRE) – via New Media Wire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States to launch the first cannabis-derived products, brands, and supply chain, today announced that its subsidiary Kannawi® Jose Miguel Gutierrez Vazquez has appointed Director of Sales for its Mexico operations.
2021 has been an exciting year for us as we have added original leaders to our international team. “I feel confident that Miguel will be another great addition due to his extensive experience and well-established relationships in Mexico,” said Blake Schroeder, CEO of Kannaway®. “Our group of companies has been a leader in cannabidiol (CBD) sales in Mexico for many years, being the first to obtain legal import permits in Mexico in 2016. Latin America has always been an important area of growth and revenue for us and we believe it will continue to do so under his leadership.”
Vazquez has over 15 years of experience in marketing, advertising and sales and boasts a proven track record of success in one of the largest nutrition companies. With an extensive background in nutrition and wellness, he has spent the past decade forming partnerships, launching new products, implementing advertising campaigns, designing loyalty programs and conducting market research in Mexico.
“Kannaway is leading the cannabis revolution and I look forward to being part of her incredible journey to bring cannabis into every home,” said Kannaway® Sales Director, Mexico Jose Miguel Gutierrez Vazquez. The company’s high-quality cannabis products paired with its superior business model are well positioned to help create positive global change. I am honored to be part of a global team and to support entrepreneurs across Mexico.”
Mexico is close to becoming the largest legal market for cannabis in the world. according to statista, the market value of CBD in Mexico was estimated to be approximately $9 million in 2020 and is expected to increase by more than 580%, to exceed $60 million by 2024.
To learn more about Kannaway®, please visit the website https://kannaway.com/.
Kannawi® is a network sales and marketing company specializing in the sale and marketing of plant based cannabis products. Currently, Kannaway® hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity for sales professionals who wish to become successful leaders in the sale and marketing of plant-based, hemp-based products.
About Medical Marijuana, Inc.
We are Firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company comprising three distinct business units in the non-psychoactive cannabis space: a global group of cannabis-based food brands led by Kannawi® And HempMeds®; A leader in sourcing high-quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the sector of cannabis-based clinical research and development of plant-based medicines led by pharmaceutical investment firms and partners including AXIM® Biotechnologies, Inc. And Neuropathics. Medical Marijuana, Inc. was selected. As the best CBD product ever CNBC. Medical Marijuana, Inc. Also the first company to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a pioneer in developing international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in. In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. Watch the Medical Marijuana, Inc. video. , click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor law created by those sections. This material contains statements about expected future events and/or financial results of a forward-looking nature and subject to risks and uncertainties. These forward-looking statements by definition include risks, uncertainties and other factors that may cause Medical Marijuana, Inc.’s actual results, performance, or achievements to differ. for the data provided here.
Disclosure by the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not. Selling or distributing any products that violate the Controlled Substances Act in the United States.
Public Relations Contact:
Investor Relations Contact:
p. (858) 283-4016